Expert clinical management of autoimmune hepatitis in the real worldRodrigo Liberal, Ynto S. de Boer, Raúl J. Andrade et al.|Alimentary Pharmacology & Therapeutics|2016Cited by 89
Efficacy and safety of infliximab in patients with autoimmune hepatitisCumali Efe, Fatima Higuera‐de la Tijera, Ellina Lytvyak et al.|Hepatology|2024Cited by 25
P499 Accessing ultrasonographic transmural healing in patients with Crohn’s disease after induction therapy with infliximab: should we aim for higher infliximab trough levels?B Morão, Carolina Palmela, C Macedo et al.|Journal of Crohn s and Colitis|2022Cited by 1
P375 Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn’s disease patientsJoana Revés, Carolina Palmela, B Morão et al.|Journal of Crohn s and Colitis|2022Cited by 0
P145 Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective studyCatarina Nascimento, Carolina Palmela, C Frias Gomes et al.|Journal of Crohn s and Colitis|2022Cited by 0